Sino Biological Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100004Q23
CNY
60.64
-1.51 (-2.43%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
693.89
613.65
646.33
567.85
953.38
1,572.24
178.64
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
693.89
613.65
646.33
567.85
953.38
1,572.24
178.64
Raw Material Cost
246.15
225.15
165.23
112.75
74.41
56.38
35.86
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
78.41
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.45
4.59
4.14
3.11
2.55
0.44
0.21
Selling and Distribution Expenses
270.37
265.84
255.80
187.55
134.10
144.49
82.16
Other Expenses
7.07
7.30
6.96
5.04
3.36
2.43
-5.66
Total Expenditure (Excl Depreciation)
590.72
568.58
494.76
353.80
244.63
225.58
140.01
Operating Profit (PBDIT) excl Other Income
103.2
45.099999999999994
151.6
214.1
708.8
1346.6999999999998
38.6
Other Income
79.99
111.94
145.83
156.62
117.44
-32.97
1.96
Operating Profit (PBDIT)
271.33
241.74
359.03
403.81
849.82
1,320.08
49.05
Interest
3.45
4.59
4.14
3.11
2.55
0.44
0.21
Exceptional Items
24.63
4.88
10.98
-14.38
34.14
6.40
0.26
Gross Profit (PBDT)
447.74
388.50
481.10
455.10
878.96
1,515.86
142.78
Depreciation
101.27
100.70
77.92
43.81
35.96
12.94
9.83
Profit Before Tax
191.23
141.33
287.95
342.51
845.45
1,313.11
39.27
Tax
31.80
19.41
27.82
39.55
125.44
185.50
2.86
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
147.74
121.93
260.13
302.96
720.01
1,127.61
36.41
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
147.74
121.93
260.13
302.96
720.01
1,127.61
36.41
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
147.74
121.93
260.13
302.96
720.01
1,127.61
36.41
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
5,314.83
5,772.91
6,366.98
6,369.10
6,752.31
1,298.64
149.81
Earnings per share (EPS)
1.21
0.95
2.01
2.34
5.57
8.73
0.28
Diluted Earnings per share
1.21
0.95
2.01
2.34
5.57
8.73
0.28
Operating Profit Margin (Excl OI)
12.98%
4.74%
20.93%
35.82%
73.05%
85.24%
20.85%
Gross Profit Margin
42.15%
39.44%
56.61%
68.03%
92.45%
84.34%
27.49%
PAT Margin
21.29%
19.87%
40.25%
53.35%
75.52%
71.72%
20.38%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 13.07% vs -5.04% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 21.16% vs -53.13% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 47.38% vs -39.12% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -26.09% vs 12.20% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Sino Biological Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
693.89
0
693.89
Other Operating Income
0.00
0.00
0.00
Total Operating income
693.89
0
693.89
Raw Material Cost
246.15
0
246.15
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
3.45
0
3.45
Selling and Distribution Expenses
270.37
0
270.37
Other Expenses
7.07
0.00
7.07
Total Expenditure (Excl Depreciation)
590.72
0
590.72
Operating Profit (PBDIT) excl Other Income
103.18
0.00
103.18
Other Income
79.99
0
79.99
Operating Profit (PBDIT)
271.33
0
271.33
Interest
3.45
0
3.45
Exceptional Items
24.63
0
24.63
Gross Profit (PBDT)
447.74
0
447.74
Depreciation
101.27
0
101.27
Profit Before Tax
191.23
0
191.23
Tax
31.80
0
31.80
Provisions and contingencies
0
0
0.00
Profit After Tax
147.74
0
147.74
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
147.74
0
147.74
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
147.74
0
147.74
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
5,314.83
0
5,314.83
Earnings per share (EPS)
1.21
0
1.21
Diluted Earnings per share
1.21
0
1.21
Operating Profit Margin (Excl OI)
12.98%
0%
0.00
12.98%
Gross Profit Margin
42.15%
0%
0.00
42.15%
PAT Margin
21.29%
0%
0.00
21.29%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 69.39 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 13.07% vs -5.04% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 14.77 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 21.16% vs -53.13% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 19.13 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 47.38% vs -39.12% in Dec 2024

Annual - Interest
Interest 0.34 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -26.09% vs 12.20% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.98%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024